Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Post by ISAloser247on Oct 10, 2012 6:40pm
464 Views
Post# 20470862

'EDMONTON RESEARCHERS MAKE RHEMATOID

'EDMONTON RESEARCHERS MAKE RHEMATOID

ARTHRITIS BREAKTHROUGH'-----November 07, 20000.  CBC NEWS.

       A new drug, undergoing final testing by an Edmonton company, could give new hope to people suffering from rheumatoid arthritis, or those needing organ transplants.   "Our drug was shown to be three to five times more potent than cyclosporin in all the animal models test'  says Yatscoff.

      Yatscoff says initial test on humans showed no kidney damage or negative side-effects.  That finding has fast-tracked the nest two levels of testing.

      THE NEW DRUG COULD BE ON THE MARKET WITHIN 30 MONTHS.

OL' RANDY, THE MASTER  BAITER OF HYPE!!!!!!!!!!

<< Previous
Bullboard Posts
Next >>